Oxford Biomedica PLCOxford Biomedica PLCOxford Biomedica PLC

Oxford Biomedica PLC

No trades
See on Supercharts
Next report date
Report period
H2 2023
EPS estimate
−0.63USD
Revenue estimate
‪60.47 M‬USD
Market capitalization
‪272.19 M‬USD
‪−47.36 M‬USD
‪169.30 M‬USD
‪67.70 M‬
Beta (1Y)
0.79

About OXFORD BIOMEDICA ORD GBP0.50

CEO
Frank Mathias
Headquarters
Oxford
Employees (FY)
904
Founded
1995
ISIN
GB00BDFBVT43
FIGI
BBG000D0R6Y4
Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The firm also provides bioprocessing and process development services to third parties. It operates through the following segments: Platform and Product. The Platform segment consists of the revenue generating bioprocessing and process development activities undertaken for third parties. The Product segment includes clinical and preclinical development of in vivo and ex vivo gene and cell therapy products which are owned by the group. The company was founded by Alan J. Kingsman and Susan M. Kingsman in 1995 and is headquartered in Oxford, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OXBDF is 2.82 USD — it has increased by 3.68% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Oxford Biomedica PLC stocks are traded under the ticker OXBDF.
Oxford Biomedica PLC is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
OXBDF stock is 3.55% volatile and has beta coefficient of 0.79. Check out the list of the most volatile stocks — is Oxford Biomedica PLC there?
OXBDF earnings for the last quarter are −0.17 USD per share, whereas the estimation was −0.08 USD resulting in a −117.85% surprise. The estimated earnings for the next quarter are −0.45 USD per share. See more details about Oxford Biomedica PLC earnings.
Oxford Biomedica PLC revenue for the last quarter amounts to ‪91.89 M‬ USD despite the estimated figure of ‪79.58 M‬ USD. In the next quarter revenue is expected to reach ‪78.95 M‬ USD.
Yes, you can track Oxford Biomedica PLC financials in yearly and quarterly reports right on TradingView.
OXBDF stock has risen by 7.84% compared to the previous week, the month change is a 16.05% rise, over the last year Oxford Biomedica PLC has showed a 48.96% decrease.
Today Oxford Biomedica PLC has the market capitalization of ‪275.22 M‬, it has increased by 8.20% over the last week.
No, OXBDF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OXBDF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oxford Biomedica PLC stock right from TradingView charts — choose your broker and connect to your account.
OXBDF reached its all-time high on Sep 23, 2021 with the price of 22.86 USD, and its all-time low was 0.02 USD and was reached on Jul 23, 2013.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 904.00 employees. See our rating of the largest employees — is Oxford Biomedica PLC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oxford Biomedica PLC technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oxford Biomedica PLC stock shows the sell signal. See more of Oxford Biomedica PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Oxford Biomedica PLC future price: according to them, OXBDF price has a max estimate of 9.22 USD and a min estimate of 2.24 USD. Read a more detailed Oxford Biomedica PLC forecast: see what analysts think of Oxford Biomedica PLC and suggest that you do with its stocks.